choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Benlysta

Benlysta Newsletter
  • A new era of lupus nephritis therapy is here 18 Sep 2025 17:33 GMT

    … of clinical trials and new FDA-approved therapies … MMF) as important treatment options for lupus … ) and belimumab (Benlysta, GlaxoSmithKline) came on … drug monitoring remained. Next-generation CNIs Subsequently, voclosporin (Lupkynis, Aurinia Pharmaceuticals …

  • AZ's bid for Fasenra approval in COPD falls short 17 Sep 2025 14:13 GMT

    … new indication for respiratory drug Fasenra in chronic obstructive … , coming after earlier negative trials, including the phase 3 … would make them suitable for treatment with biologics like Fasenra. … GSK's BLyS inhibitor Benlysta (belimumab), which is dosed …

  • Global Benlysta Market Forecast To Reach $3.6 Billion By 2029 With 11.2% Annual Growth 28 Jul 2025 12:53 GMT

    … in immunology, innovative drug delivery systems, collaborations … on medical goods and services, including hospital care, pharmaceuticals, … increased investment in treatments for chronic autoimmune … 47;report/benlysta-global-market-report What …

  • Treatment pipeline for cutaneous lupus may ‘offer hope very soon’ 18 Jul 2025 16:12 GMT

    … phase 3 trial for the drug in CLE is … topical and oral medications. These treatments are often not … stimulator (BLyS) belimumab (Benlysta, GlaxoSmithKline) to anifrolumab … , Nektar, Nuvig Pharmaceuticals, Pfizer, Regeneron, Rome Pharmaceuticals, Sanofi, Takeda …

  • Pledging ‘Radical Transparency,’ FDA Reveals Drug Rejection Letters — With Limits 13 Jul 2025 18:50 GMT

    … GSK drug at home. Intravenously infused Benlysta was … vaccine as mNEXSPIKE. In the key clinical trial … FDA approved KalVista Pharmaceuticals’ Ekterly, making the pill the first oral on-demand treatment … drug that the biotech had developed as a treatment for …

  • Key FDA approvals in pediatric health: First half of 2025 05 Jul 2025 13:34 GMT

    … vaccination rates remain low. The FDA approved epinephrine nasal spray (neffy; ARS Pharmaceuticals … 3 trials, the treatment significantly … trial, clesrovimab reduced medically … FDA approved a 200 mg/mL autoinjector formulation of belimumab (Benlysta …

  • FDA News Recap: June 2025 02 Jul 2025 15:05 GMT

    … Drug GMRx2 (WIDAPLIK) for Hypertension Treatment On June 9, 2025, George Medicines announced FDA … phase 3 trials and the VERONICA … 2025, Amneal Pharmaceuticals announced FDA approval of prednisolone … patients. FDA Approves Belimumab (Benlysta) Autoinjector for …

  • FDA news in pediatrics: June 2025 01 Jul 2025 20:03 GMT

    … treatments without medication side effects. On June 9, 2025, the FDA … phase 3 SMART trials, which demonstrated that … the CLEVER trial, clesrovimab reduced medically attended lower … (KalVista Pharmaceuticals), an investigational oral treatment for hereditary …

  • FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis 01 Jul 2025 02:29 GMT

  • FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis 30 Jun 2025 22:37 GMT

    … Food and Drug Administration has approved an autoinjector of Benlysta (belimumab … adverse reactions seen with Benlysta were serious infections, … . "Having the Benlysta autoinjector provides a much … frequent clinic visits for treatment and add greater …

Satisfied with the content?

Continue to create your account.